Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free therapeutic TNFα antibodies (adalimumab) from plasma or serum samples.
Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.
Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.
BIOHIT Faecal Calprotectin Extraction Tubes are intended for the extraction of human stool samples for measurement of calprotectin using the BIOHIT Calprotectin ELISA.
PreventID CalDetect 50/200 is a rapid immunochemical test that semi-quantitatively screens and measures calprotectin in stool samples in just 10 minutes. Faecal calprotectin is an exceptionally accurate and convenient marker for investigating bowel inflammation in patients presenting with abdominal symptoms, or monitoring those with inflammatory bowel disease (IBD).
The BIOHIT Calprotectin ELISA is a quantitative sandwich ELISA method for the detection of calprotectin in stool samples. It can be used to help identify organic diseases of the small or large intestine, and to monitor disease activity and response to treatment in patients with ulcerative colitis or Crohn’s disease.
PreventID CalScreen is a rapid immunochemical test that screens stool samples for calprotectin in just 10 minutes. With a predefined cut-off at 50 μg/g, CalScreen enables the rapid screening of patients with chronic abdominal symptoms, and the differentiation between inflammatory and non-inflammatory bowel conditions.
The BIOHIT Celiac Quick Test is a rapid immunochromatographic test for the qualitative detection of IgA, IgG, and IgM autoantibodies against human tissue transglutaminase (tTG2A) in capillary whole blood samples.
BIOHIT ColonView Hb and Hb/Hp test can be used to screen for lower gastrointestinal (GI) organic pathologies, such as colorectal cancers and large adenomas that bleed. ColonView is a new generation lateral flow faecal immunochemical test (FIT), intended for the rapid detection of faecal occult blood (FOB) in stool samples.
The CE-marked GA-map COVID-19 Fecal Test is designed to qualitatively detect SARS-CoV-2 RNA in faecal samples. This kit is suitable for patients exhibiting symptoms of COVID-19 (confirmation and management), as well as those in the recovery phase (surveillance and clearance), asymptomatic individuals concerned about possessing and transmitting the virus (prevention), and for screening faecal microbiota transplant (FMT) donors.
The innovative IDK Faecal Bile Acids assay allows quantitative determination of bile acids in stool samples. This rapid photometric assay can aid the diagnosis of bile acid diarrhoea in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS) or can be used to support differential diagnosis of bile acid malabsorption.
The IDK Faecal Calprotectin ELISA is an enzyme immunoassay for the quantitative determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples, to rule out and monitor inflammatory bowel diseases (IBDs) non-invasively.
The IDK Faecal Haemoglobin ELISA is an enzyme immunoassay for the reliable quantitative determination of human haemoglobin in stool samples, which can be used as marker for gastrointestinal bleeding, colorectal cancer and adenomatous polyps.
The IDK Lactoferrin ELISA is an enzyme immunoassay for the quantitative determination of lactoferrin – a well-established biomarker for neutrophilic intestinal inflammation – in stool samples. Faecal lactoferrin measurement supports monitoring of disease activity in inflammatory bowel disease (IBD), prediction of relapse of IBD and assessment of treatment response in IBD.
The GA-Map Dysbiosis test is the first clinical test that identifies and characterises dysbiosis based on faecal specimens. It does this by exploiting single nucleotide differences in the 16S rRNA gene – a gene that is common to all bacteria. With 48 highly specific probes, the GA-map Dysbiosis Test identifies over 300 species of bacteria using cutting edge high throughput technology.
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples.
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.
Stool samples can be extracted directly and efficiently using the IDK Stool Sample Application System, which allows easy, clean and precise preparation of stool sample extracts.
Stool samples can be extracted directly and efficiently using the IDK Stool Sample Application System, which allows easy, clean and precise preparation of sample extracts.
The IDK TurbiCAL is a particle enhanced turbidimetric immunoassay (PETIA) that uses monoclonal antibodies for the determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples.
The IDK TurbiFIT is a particle enhanced turbidimetric immunoassay (PETIA) that uses polyclonal antibodies for the determination of human haemoglobin in stool samples.
Stool samples can be extracted directly and efficiently using the IDK TurbiTUBE, which allows easy, clean and precise preparation of sample extracts.
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation which is a major cause of loss of drug response.
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.
The BIOHIT Lactose Intolerance Quick Test supports the diagnosis of lactose intolerance (hypolactasia of the small intestine) by detecting lactase enzyme activity in a duodenal biopsy specimen.
The IDK Oncostatin M (OSM) ELISA is used for the quantitative determination of oncostatin M in serum, plasma or stools. OSM and its receptor, OSMR, are involved in gut inflammation, and are upregulated in the mucosa of IBD patients.
Preventis QuantOn Cal is a test system for the quantitative determination of calprotectin in stool samples. This in vitro diagnostic device (IVD) is intended for self-testing and individual monitoring of treatment efficacy for patients with chronic inflammatory bowel disease (IBD).
Preventis SmarTest Pro Vitamin D is a rapid test system for the quantitative determination of 25(OH) vitamin D in finger-prick blood samples, ideal for GPs, pharmacies and outpatient clinics. This quantitative test supports fast and effective vitamin D supplement optimisation, and enables close monitoring of 25(OH) vitamin D levels in a point of care setting. The kit contains everything needed to prepare, collect and test a finger-prick blood sample in combination with the SmarTest Vitamin D app.
Preventis SmarTest Calprotectin is a quantitative home test system for the determination of calprotectin in stool samples. This in vitro diagnostic device (IVD) is intended for self-testing and individual monitoring of disease activity and treatment efficacy for patients with chronic inflammatory bowel disease (IBD).
The BIOHIT Total 25OH Vitamin D ELISA is a quantitative immunoenzymatic assay for the determination of 25-hydroxyvitamins D2 and D3 (25OHD2 and 25OHD3) in serum and plasma, to aid in the diagnosis of vitamin D deficiency, insufficiency or intoxication.
Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.
Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This assay enables the reliable determination of free, unbound anti-drug antibodies.
Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This drug-tolerant assay enables the reliable determination of anti-drug antibodies even in the presence of ustekinumab.
Vedolizumab is a recombinant protein used to treat Crohn’s disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.
The IDKmonitor Vedolizumab Free Anti-drug ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free anti-vedolizumab antibodies in plasma or serum samples. Detecting high levels of free anti-vedolizumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.
The IDK Zonulin (Serum) ELISA is a quantitative assay for the determination of zonulin in serum. Zonulin is a protein that is involved in intestinal barrier function, and has been highlighted as a potential marker of so called “leaky gut” syndrome.
The IDK Zonulin (Stool) ELISA is a quantitative assay for the determination of zonulin in stool samples. Zonulin is a protein that is involved in intestinal barrier function, and has been highlighted as a potential marker of so called “leaky gut” syndrome.